期刊文献+

冠心病合并糖尿病患者抗血小板药物治疗 被引量:10

Anti-platelet Drug Therapy in Coronary Artery Disease Patients with Diabetes Mellitus
下载PDF
导出
摘要 随着对冠心病和糖尿病研究的日益深入,两者间的密切关系也越来越得到医务人员的重视。冠心病合并糖尿病的患者发生各种心血管事件的风险明显增加,因此在冠心病合并糖尿病患者中普及甚至加强抗血小板治疗显得尤为重要。现就最近冠心病合并糖尿病患者抗血小板治疗的最新研究进展做一综述。 With the deepening of coronary heart disease and diabetes mellitus research, the close relationship between those gets more and more attention from the medical staff. Coronary heart disease with diabetic patients have significantly increased risk of various cardiovascular events, so popularizing even strengthening antiplatelet therapy is particularly important in these patients. Then, the review stated the latest research progress on the antiplatelet therapy in coronary heart disease patients with diabetes mellitus.
出处 《心血管病学进展》 CAS 2013年第5期613-616,共4页 Advances in Cardiovascular Diseases
基金 国家"十二五"科技支撑计划资金资助(2011BAI11B07)
关键词 冠心病 糖尿病 抗血小板治疗 coronary heart disease diabetes mellitus antiplatelet therapy
  • 相关文献

参考文献28

  • 1Chazova 'rE, Masenko VP, Zykov KA, et al. The role of inflammation factors in development of acute coronary syndrome in patients with type 2 diabetes menitus and impaired glucose tolerance[J]. 'tier Arkh, 2007, 79(6) :60-64.
  • 2Ryden L, Standl E, Barmik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology ( ESC ) and of the European Association for the Study of Diabetes (EASD) [J]. Eur Heart J, 2007, 28( 1 ):88-136.
  • 3Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis [J]. JAMA, 2006, 295(2) :180-189.
  • 4National Cholesterol Education Program (NCEP) Expert Panel on Detection, E- valuation, and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel Jl ). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel ) final report [J]. Circulation,2002,106 (25) :3143-3421.
  • 5Beckman JA, Croager MA, Libby P. Diabetes and atherosclerosis: epidemiolo- gy, pathophysiology, and management [J]. JAMA, 2002, 287 (19) :2570- 2581.
  • 6Biondi-Zoccai CoG, Abbate A, Liuzzo G, et al. Atherothrombosis, inflamma- tion, and diabetes [ J ]. J Am Coil Cardio1,2003,41 ( 7 ) : 1071 - 1077.
  • 7Steering Committee of the Physicians' Health Study Research Group. Final re- port on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group [ J ]. N Engl J Med, 1989,321 (3) : 129-135.
  • 8No authors listed. Aspirin effects on mortality and morbidity in patients with dia- betes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators [J]. JAMA, 1992, 268(10) :1292-1300.
  • 9Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arte- rial disease and diabetes (POPADAD) trial: factorial randomised placebo con- trolled trial of aspirin and antioxidants in patients with diabetes and asymptomat- ic peripheral arterial disease[J]. BMJ,2008,337:a1840.
  • 10Antithrombotic Trialists' Collaboration. Colla})orative meta-analysis of random- ised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients [ J ]. BMJ ,2002,324 (7329) :71-86.

同被引文献73

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部